tradingkey.logo
tradingkey.logo
Search

Sunshine Biopharma Inc

SBFM
Add to Watchlist
1.150USD
-0.080-6.50%
Close 07-31 16:00ETQuotes delayed by 15 min
564.18KMarket Cap
LossP/E TTM

SBFM Financials

See Sunshine Biopharma Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Sunshine Biopharma Inc Earnings Date

Latest Release
May 13, 2026
EPS / Forecast
-0.25/--
Revenue / Forecast
8.09M/--
Period
FY2025 Earnings
Revenue(YoY)
36.31M
4.11%
EPS(YoY)
-14.37
-96.47%
Analyst Rating
BUY
2026/07/31
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
-480.95%-2.54
56.03%-0.44
79.47%-0.19
96.04%-0.39
98.91%-0.44
99.04%-1.00
98.14%-0.94
86.03%-9.94
74.09%-40.04
95.01%-105.02
---50.72
---71.17
---154.52
---2.10K
---505.42
----
----
----
----
----
Revenue
-9.13%8.09M
-10.61%8.58M
11.64%9.42M
1.15%9.41M
18.04%8.90M
24.93%9.59M
41.59%8.44M
67.30%9.30M
54.09%7.54M
94.94%7.68M
4385.93%5.96M
3599.67%5.56M
3890.42%4.89M
4528.68%3.94M
163.63%132.81K
184.27%150.31K
206.17%122.64K
203.85%85.12K
193.74%50.38K
249.12%52.87K
Net Profit
-5.43%-1.24M
0.80%-2.14M
26.21%-883.82K
-258.25%-1.77M
8.10%-1.18M
-72.65%-2.16M
-83.86%-1.20M
45.21%-494.30K
24.59%-1.28M
94.68%-1.25M
55.29%-651.48K
-67.41%-902.11K
-37.71%-1.70M
-3624.47%-23.51M
63.93%-1.46M
81.28%-538.87K
80.01%-1.24M
161.55%667.12K
-478.22%-4.04M
-217.27%-2.88M
Net Margin
-16.02%-15.38%
-10.97%-24.96%
33.91%-9.39%
-254.17%-18.82%
22.15%-13.25%
-38.20%-22.49%
-29.86%-14.20%
67.25%-5.31%
51.06%-17.02%
97.27%-16.28%
---10.94%
---16.22%
---34.79%
---596.78%
---796.56%
----
----
----
----
----
Gross Margin
-13.13%26.01%
8.26%34.16%
-4.79%31.62%
43.67%35.60%
-2.31%29.95%
-4.05%31.55%
1.31%33.21%
-28.15%24.78%
-16.34%30.66%
-11.99%32.89%
--32.78%
--34.49%
--36.64%
--37.37%
--49.11%
----
----
----
----
----
Debt to assets ratio
----
----
----
----
----
----
----
----
----
----
--0.00%
--0.00%
----
--0.00%
--0.00%
----
----
----
----
----
Revenue
-9.13%8.09M
-10.61%8.58M
11.64%9.42M
1.15%9.41M
18.04%8.90M
24.93%9.59M
41.59%8.44M
67.30%9.30M
54.09%7.54M
94.94%7.68M
4385.93%5.96M
3599.67%5.56M
3890.42%4.89M
4528.68%3.94M
163.63%132.81K
184.27%150.31K
206.17%122.64K
203.85%85.12K
193.74%50.38K
249.12%52.87K
Operating profit
-7.71%-1.40M
18.62%-1.66M
51.92%-531.96K
21.72%-992.85K
4.06%-1.30M
-71.64%-2.04M
-41.94%-1.11M
-25.09%-1.27M
26.16%-1.35M
76.43%-1.19M
54.63%-779.47K
-45.72%-1.01M
-49.50%-1.83M
-1701.26%-5.04M
-246.19%-1.72M
-79.05%-695.80K
4.10%-1.22M
18.55%-279.63K
-637.51%-496.26K
-202.25%-388.60K
Net Profit
-5.43%-1.24M
0.80%-2.14M
26.21%-883.82K
-258.25%-1.77M
8.10%-1.18M
-72.65%-2.16M
-83.86%-1.20M
45.21%-494.30K
24.59%-1.28M
94.68%-1.25M
55.29%-651.48K
-67.41%-902.11K
-37.71%-1.70M
-3624.47%-23.51M
63.93%-1.46M
81.28%-538.87K
80.01%-1.24M
161.55%667.12K
-478.22%-4.04M
-217.27%-2.88M
Current assets
1.23%24.78M
3.42%26.85M
7.64%27.97M
8.17%27.85M
-15.09%24.48M
4.32%25.97M
2.15%25.98M
-1.34%25.75M
15.57%28.83M
-8.87%24.89M
-37.75%25.43M
-37.84%26.10M
86.10%24.95M
1143.83%27.31M
1539.88%40.86M
2228.10%41.99M
627.83%13.41M
114.03%2.20M
372.26%2.49M
1507.98%1.80M
Total current liabilities
2.01%5.88M
2.04%6.44M
46.88%6.65M
5.18%5.57M
-11.80%5.76M
13.74%6.31M
-11.00%4.53M
13.71%5.30M
-5.39%6.53M
-19.90%5.55M
959.56%5.09M
4351.82%4.66M
7151.30%6.91M
7497.38%6.93M
1.82%480.21K
-83.53%104.68K
-88.99%95.23K
-91.32%91.23K
-36.93%471.63K
5.48%635.56K
Total assets
-4.31%27.93M
-1.57%30.08M
4.76%31.49M
9.09%31.97M
-8.50%29.19M
11.75%30.56M
8.70%30.06M
3.14%29.30M
18.18%31.90M
-6.49%27.35M
-32.34%27.65M
-32.34%28.41M
101.29%26.99M
1227.52%29.24M
1533.32%40.86M
2210.92%41.99M
621.53%13.41M
110.71%2.20M
354.46%2.50M
1211.80%1.82M
Total liabilities
-1.09%6.41M
-0.27%7.04M
45.25%7.29M
8.08%6.28M
-8.40%6.48M
14.99%7.06M
-11.77%5.02M
9.64%5.81M
-6.38%7.08M
-19.39%6.14M
1084.23%5.69M
4963.07%5.30M
7840.30%7.56M
282.49%7.62M
-86.94%480.21K
-96.11%104.68K
-96.76%95.23K
-0.45%1.99M
232.54%3.68M
304.00%2.69M
Total equity
-5.22%21.52M
-1.97%23.04M
-3.35%24.20M
9.34%25.68M
-8.53%22.70M
10.81%23.50M
14.00%25.04M
1.64%23.49M
27.74%24.82M
-1.94%21.21M
-45.61%21.96M
-44.83%23.11M
45.93%19.43M
10117.97%21.63M
3540.07%40.38M
4899.56%41.89M
1327.80%13.31M
122.17%211.66K
-111.57%-1.17M
-65.52%-872.71K
Net operating income
-20.90%-2.07M
52.57%-1.62M
46.52%-727.80K
72.18%-1.27M
46.19%-1.71M
-26.68%-3.41M
-197.61%-1.36M
-21.17%-4.58M
-72.16%-3.19M
-19.72%-2.69M
59.31%-457.29K
-558.42%-3.78M
-41.86%-1.85M
-619.81%-2.25M
-87.04%-1.12M
7.28%-573.80K
-338.60%-1.30M
26.33%-312.11K
-398.28%-600.81K
-654.55%-618.85K
Net investment
40.62%-104.52K
90.55%-50.21K
79.55%-118.30K
9.30%-491.78K
73.68%-176.02K
-97.43%-531.53K
-3166.80%-578.37K
-108.96%-542.21K
-357.09%-668.74K
98.16%-269.23K
--18.86K
---259.48K
---146.30K
---14.62M
----
----
----
100.00%0.00
----
----
Net financing
-100.00%0.00
-64.73%724.50K
-95.95%75.54K
12730.71%3.61M
-93.74%338.14K
6830.20%2.05M
3035.46%1.87M
-100.70%-28.58K
1102.82%5.40M
98.54%-30.52K
---63.57K
-86.07%4.06M
-104.33%-538.30K
-8758.42%-2.10M
-100.00%0.00
5188.98%29.12M
1028.65%12.44M
-102.56%-23.66K
143.16%1.28M
246.30%550.65K

FAQs

What is the total revenue of Sunshine Biopharma Inc?

According to Sunshine Biopharma Inc's FY2025 earnings report, its total revenue reached 36.31M, with a year-on-year change of 34.87M.

What are the current assets of Sunshine Biopharma Inc?

According to Sunshine Biopharma Inc's FY2025 earnings report, its current assets were 26.85M, with a year-on-year change of 3.42.

What are the total assets of Sunshine Biopharma Inc?

According to Sunshine Biopharma Inc's FY2025 earnings report, its total assets of Sunshine Biopharma Inc were 30.08M, with a year-on-year change of -1.57.

What are the total liabilities of Sunshine Biopharma Inc?

According to Sunshine Biopharma Inc's FY2025 earnings report, its total liabilities of Sunshine Biopharma Inc were 7.04M, with a year-on-year change of -0.27.

What is the total equity of Sunshine Biopharma Inc?

According to Sunshine Biopharma Inc's FY2025 earnings report, its total equity of Sunshine Biopharma Inc was 23.04M, with a year-on-year change of -1.97.

What is the net operating income of Sunshine Biopharma Inc?

According to Sunshine Biopharma Inc's FY2025 earnings report, its net operating income of Sunshine Biopharma Inc was -4.48M, with a year-on-year change of 22.94.

What is the net investment of Sunshine Biopharma Inc?

According to Sunshine Biopharma Inc's FY2025 earnings report, its net investment of Sunshine Biopharma Inc was -836.31K, with a year-on-year change of 63.97.

What is the net financing of Sunshine Biopharma Inc?

According to Sunshine Biopharma Inc's FY2025 earnings report, its net financing of Sunshine Biopharma Inc was 4.75M, with a year-on-year change of -48.88.

What is the Earnings Per Share (EPS) of Sunshine Biopharma Inc?

According to Sunshine Biopharma Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -14.37, with a year-on-year change of -96.47.

What is the net income of Sunshine Biopharma Inc?

According to Sunshine Biopharma Inc's FY2025 earnings report, its net income was -5.98M, with a year-on-year change of -16.39.

What is the net margin of Sunshine Biopharma Inc?

According to Sunshine Biopharma Inc's FY2025 earnings report, its net profit margin was -16.46, with a year-on-year change of -11.80.

What is the gross margin of Sunshine Biopharma Inc?

According to Sunshine Biopharma Inc's FY2025 earnings report, its gross margin was 32.84, with a year-on-year change of 9.64.

What is the Return on Equity (ROE) of Sunshine Biopharma Inc?

According to Sunshine Biopharma Inc's FY2025 earnings report, its Return on Equity (ROE) was -25.69, with a year-on-year change of -11.83.

What is the Return on Assets (ROA) of Sunshine Biopharma Inc?

According to Sunshine Biopharma Inc's FY2025 earnings report, its Return on Assets (ROA) was -19.71, with a year-on-year change of -11.14.

What is the operating profit of Sunshine Biopharma Inc?

According to Sunshine Biopharma Inc's FY2025 earnings report, its operating profit was -4.48M, with a year-on-year change of 22.94.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.